Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis

Journal of Controlled Release

Volumn 162, Issue 1, 2012, Pages 111-118

  Cho, Hyun Jong ^a   Yoon, Hong Yeol ^b   Koo, Heebeom ^c   Ko, Seung Hak ^d   Shim, Jae Seong ^d,e   Cho, Jee Hyun ^f   Park, Jae Hyung ^b   Kim, Kwangmeyung ^c   Kwon, Ick Chan ^c   Kim, Dae Duk ^g  

^a Sunchon National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Biogenics Inc   (South Korea)

^e Skin Tech Inc   (South Korea)

^f Korea Basic Science Institute (KBSI)   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Dual modality; Hyaluronic acid ceramide; MRI; NIRF; Tumor targeting

Indexed keywords

CANCER DIAGNOSIS; CELLULAR UPTAKE EFFICIENCY; CONTRAST ENHANCEMENT; DISTRIBUTED PARTICLES; DUAL IMAGING; DUAL MODALITY; HYALURONIC ACID-CERAMIDE; IN-VITRO; IN-VIVO; MOUSE MODELS; MR CONTRAST AGENTS; MR SIGNALS; NEAR-INFRARED FLUORESCENCE; NIRF; OPTICAL IMAGING; RECEPTOR INTERACTION; SELF-ASSEMBLED; TUMOR TARGETING; TUMOR XENOGRAFTS;

AMIDES; DIAGNOSIS; DISEASES; GADOLINIUM; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; ORGANIC ACIDS; TUMORS;

NANOPROBES;

CERAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; HERMES ANTIGEN; HYALURONIC ACID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PENTETIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER DIAGNOSIS; CHELATION; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DRUG FORMULATION; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; MORPHOLOGY; MOUSE; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; CERAMIDES; CHELATING AGENTS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS;

EID: 84864663396     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.06.011     Document Type: Article

References (30)

1. C. Claus, R. Rossin, M.J. Welch, and G. Bao In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent Bioconjug. Chem. 21 2010 715 722
2. M. Jauregui-Osoro, P.A. Williamson, A. Glaria, K. Sunassee, P. Charoenphun, M.A. Green, G.E. Mullen, and P.J. Blower Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging Dalton Trans. 40 2011 6226 6237
3. J.M. Criscione, L.W. Dobrucki, Z.W. Zhuang, X. Papademetris, M. Simons, A.J. Sinusas, and T.M. Fahmy Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging Bioconjug. Chem. 22 2011 1784 1792
4. Y. Koyama, V.S. Talanov, M. Bernardo, Y. Hama, C.A. Regino, M.W. Brechbiel, P.L. Choyke, and H. Kobayashi A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice J. Magn. Reson. Imaging 25 2007 866 871
5. S.H. Yuk, K.S. Oh, S.H. Cho, B.S. Lee, S.Y. Kim, B.K. Kwak, K. Kim, and I.C. Kwon Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging Biomacromolecules 12 2011 2235 2243
6. J.C. Park, M.K. Yu, G.I. An, S.I. Park, J. Oh, H.J. Kim, J.H. Kim, E.K. Wang, I.H. Hong, Y.S. Ha, T.H. Choi, K.S. Jeong, Y. Chang, M.J. Welch, S. Jon, and J. Yoo Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging Small 6 2010 2863 2868
7. J.S. Kim, Y.H. Kim, J.H. Kim, K.W. Kang, E.L. Tae, H. Youn, D. Kim, S.K. Kim, J.T. Kwon, M.H. Cho, Y.S. Lee, J.M. Jeong, J.K. Chung, and D.S. Lee Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation Nanomedicine 7 2012 219 229
8. D. Kryza, J. Taleb, M. Janier, L. Marmuse, I. Miladi, P. Bonazza, C. Louis, P. Perriat, S. Roux, O. Tillement, and C. Billotey Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theranostic agent Bioconjug. Chem. 22 2011 1145 1152
9. G.J. Strijkers, W.J. Mulder, G.A. van Tilborg, and K. Nicolay MRI contrast agents: current status and future perspectives Anticancer Agents Med Chem. 7 2007 291 305
10. T. Nam, S. Park, S.Y. Lee, K. Park, K. Choi, I.C. Song, M.H. Han, J.J. Leary, S.A. Yuk, I.C. Kwon, K. Kim, and S.Y. Jeong Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging Bioconjug. Chem. 21 2010 578 582
11. O. Veiseh, C. Sun, J. Gunn, N. Kohler, P. Gabikian, D. Lee, N. Bhattarai, R. Ellenbogen, R. Sze, A. Hallahan, J. Olson, and M. Zhang Optical and MRI multifunctional nanoprobe for targeting gliomas Nano Lett. 5 2005 1003 1008
12. M.P. Melancon, W. Lu, Q. Huang, P. Thapa, D. Zhou, C. Ng, and C. Li Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813 Biomaterials 31 2010 6567 6573
13. K.H. Chung, M.Y. Cho, M.H. Sung, H. Poo, and Y.T. Lim Electrostatically assembled biocompatible polymer nanoparticles for MR/optical dual-modality imaging nanoprobes Chem. Commun. 47 2011 8889 8891
14. C.M. Lee, D. Jang, J. Kim, S.J. Cheong, E.M. Kim, M.H. Jeong, S.H. Kim, D.W. Kim, S.T. Lim, M.H. Sohn, Y.Y. Jeong, and H.J. Jeong Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo Bioconjug. Chem. 22 2011 186 192
15. D.A. Ossipov Nanostructured hyaluronic acid-based materials for active delivery to cancer Expert Opin. Drug Deliv. 7 2010 681 703
16. V. Orian-Rousseau CD44, a therapeutic target for metastasising tumours Eur. J. Cancer 46 2010 1271 1277
17. K.Y. Choi, H. Chung, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, I.C. Kwon, and S.Y. Jeong Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 31 2010 106 114
18. K.Y. Choi, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, I.C. Kwon, K. Choi, and S.Y. Jeong PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo Biomaterials 32 2011 1880 1889
19. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Lee, K. Kim, I.C. Kwon, and D.D. Kim Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
20. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
21. H. Yim, S.G. Yang, Y.S. Jeon, I.S. Park, M. Kim, D.H. Lee, Y.H. Bae, and K. Na The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI Biomaterials 32 2011 5187 5194
22. J.P. Kratohvil, W.P. Hsu, and D.I. Kwok How large are the micelles of di-α-hydroxy bile salts at the critical micellization concentrations in aqueous electrolyte solutions? Results for sodium taurodeoxycholate and sodium deoxycholate Langmuir 2 2002 256 258
23. J.N. Phillips The energetics of micelle formation, J. N. Trans. Faraday Soc. 51 1995 561 569
24. K.K. Upadhyay, A.N. Bhatt, A.K. Mishra, B.S. Dwarakanath, S. Jain, C. Schatz, J.F. Le Meins, A. Farooque, G. Chandraiah, A.K. Jain, A. Misra, and S. Lecommandoux The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes Biomaterials 31 2010 2882 2892
25. K.J. Chen, S.M. Wolahan, H. Wang, C.H. Hsu, H.W. Chang, A. Durazo, L.P. Hwang, M.A. Garcia, Z.K. Jiang, L. Wu, Y.Y. Lin, and H.R. Tseng A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity Biomaterials 32 2011 2160 2165
26. M.E. Bartolini, J. Pekar, D.R. Chettle, F. McNeill, A. Scott, J. Sykes, F.S. Prato, and G.R. Moran An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis Magn. Reson. Imaging 21 2003 541 544
27. 2-weighted magnetic resonance imaging Bioconjug. Chem. 21 2010 505 512
28. P. Caraban Strategies for increasing the sensitivity of gadolinium based MRI contrast agents Chem. Soc. Rev. 35 2006 512 523
29. Y. Liu, Z. Chen, C. Liu, D. Yu, Z. Lu, and N. Zhang Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer Biomaterials 32 2011 5167 5176
30. D.P. Lankveld, A.G. Oomen, P. Krystek, A. Neigh, A. Troost-de Jong, C.W. Noorlander, J.C. Van Eijkeren, R.E. Geertsma, and W.H. De Jong The kinetics of the tissue distribution of silver nanoparticles of different sizes Biomaterials 31 2010 8350 8361